Childhood hepatocellular carcinoma: a clinicopathological study of 12 cases with special reference to EpCAM

Yoh Zen1, Roshni Vara, Bernard Portmann

  • 1Histopathology Section, Institute of Liver Studies, King's College Hospital, London, UK.

Histopathology
|October 22, 2013
PubMed

Insights

Childhood hepatocellular carcinoma (HCC) is characterized by diffuse epithelial cell adhesion molecule (EpCAM) expression, distinguishing it from adult HCC and other pediatric liver tumors. This finding may suggest immature neoplastic cells in pediatric HCC.

Area of Science:

  • Pediatric oncology
  • Hepatocellular carcinoma research
  • Tumor marker analysis

Background:

  • Hepatocellular carcinoma (HCC) is rare in children.
  • Understanding pediatric HCC characteristics is crucial for diagnosis and treatment.
  • Comparison with adult HCC, fibrolamellar HCC, and hepatoblastoma is needed.

Observation:

  • Twelve pediatric HCC cases were analyzed and compared to adult HCC, fibrolamellar HCC, and hepatoblastoma.
  • Childhood HCCs arose in the context of specific underlying conditions like tyrosinaemia type 1 and bile salt export transporter deficiency.
  • Morphological and immunohistochemical features were evaluated.

Findings:

  • Childhood HCC consistently showed diffuse epithelial cell adhesion molecule (EpCAM) expression, particularly in younger children.
  • EpCAM expression was focal in adult HCC, differentiating it from pediatric cases.
  • Other markers like CK7, β-catenin, and p53 also distinguished childhood HCC from fibrolamellar HCC and hepatoblastoma.

Implications:

  • Diffuse EpCAM expression is a potential hallmark of pediatric HCC.
  • This marker may indicate immature neoplastic cells in childhood liver cancer.
  • Further research into EpCAM's role could improve diagnostic accuracy and therapeutic strategies for pediatric HCC.
Abstract

Related Concept Videos